RxDoctor Payments DataLook up a doctor →

Ivan Cichowicz, MD

Geriatric Psychiatry · Boca Raton, FLNPI 1932312840

Payments from drug & device makers

$781,837in general payments, 2019–2025

Across 1,109 payments — averaging $704.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$465K
  • Johnson & Johnson$186K
  • Janssen Research & Development, LLC$59K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$11K
  • Otsuka America Pharmaceutical, Inc.$2K
  • plus $7K from 21 others
$1,499in research payments, 2019–2025

Across 13 payments — averaging $115.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1K

What the payments were for

  • Consulting fees$5,5002%
  • Speaking & faculty fees$206,93581%
  • Travel & lodging$23,4589%
  • Food & beverage$18,8057%
  • Education$870%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$781,837 in reported general payments places this provider in the 90th percentile of 33 geriatric psychiatry providers in Florida.

See all geriatric psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$1,008,722
Medicare patients
439
Services billed
5,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate21$153,090
AustedoDeutetrabenazine16$112,105
IngrezzaValbenazine Tosylate12$102,089
TrintellixVortioxetine Hydrobromide101$83,433
RexultiBrexpiprazole38$70,983
CaplytaLumateperone Tosylate41$65,217
LybalviOlanzapine/Samidorphan Malate13$19,545
VraylarCariprazine Hcl11$17,115
Vilazodone Hcl177$14,860
AuvelityDextromethorphan Hbr/Bupropion15$14,244
Lurasidone Hcl69$12,283
Aripiprazole207$12,097
DayvigoLemborexant31$12,057
Bupropion XlBupropion Hcl216$5,307
Desvenlafaxine Succinate ErDesvenlafaxine Succinate97$4,731

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$246$153,09021 claims
Teva Pharmaceuticals USA, Inc.Austedo$1,368$112,10516 claims
Neurocrine Biosciences, Inc.Ingrezza$230$102,08912 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$1,030$83,433101 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,748$70,98338 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$52,445$65,21741 claims
Alkermes, Inc.Lybalvi$556$19,54513 claims
AbbVieVraylar$1,107$17,11511 claims
Axsome Therapeutics, Inc.Auvelity$419$14,24415 claims
Lilly USA, LLCOlanzapine$118$2,975107 claims
Almatica Pharma LLCSertraline Hcl$72$96892 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 33 geriatric psychiatry providers in Florida.

Other geriatric psychiatry in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →